StocksRunner logo
 
  Overview  
 
  Chart  
 
  Earnings  
 
  Sentiment  
 
  News  
 
  Updates  
 
 
 
CVS Guidance
77.20
+0.13%
 

CVS

 

CVS Guidance

$ 77.20

 
+$0.10 | +0.13%
 
 
Open
$ 77.29
 
 
MKT CAP
$ 97.15B
 
High
$ 77.52
 
 
VOL
$ 4.32M
 
Low
$ 76.62
 
 
AVG VOL
$ 12.42M
 
 
 

CVS Stock Analysis

  Login to display CVS Guidance (CVS) recommendation from the last 90 days from financial news and social media.
 
 

CVS Total Score

 

Chart

 
 

78.93

69.42

70.92

82.47

 
 
1month
3month
6month
1year
 
Total Return
CVS
vs.
S&P500
 

 
1-week Return
+0.78%
 
+1.17%
 
 
5-week Return
+4.42%
 
+6.44%
 
 
10-week Return
+4.66%
 
+10.09%
 
 
 
 

Strengths

CVS Rewards

 Earnings are forecast to grow

CVS Rewards

 Trading below its fair value

CVS Rewards

 Investors confidence is positive

CVS Rewards

 Insider buying over the past 3 months

 

Risk Analysis

CVS Risk Analysis

 Downgraded on weak valued

 
 

CVS Risk Level

This Indicator assigning risk levels based on factors such as volatility, sector strength, trading volume, investor confidence and market outlook.

 
CVS Risk Level
LOW
HIGH

Risk Volatility

 

CVS has Low Risk Level

Click here to check what is your level of risk

 

CVS Analysts Opinion

The company overall standing based on key factors, offering insights into analysts perspectives and market expectations. Hover over the category for more information

 
 

Earnings

×
 

Earnings

3.90
 

CVS Earnings Sentiment

 Sales increase

CVS Earnings Sentiment

 Above analyst estimates

CVS Earnings Sentiment

 Revenue increase YoY

 
 

Rating

×
 

Rating

2.00
 

CVS Rating Sentiment

 Downgraded on weak valued

 

Momentum

×
 

Momentum

3.00
 

CVS Momentum Analysis

 Price value has negative momentum

 

Activity

×
 

Activity

3.48
 

CVS Activity Sentiment

 Investors confidence is positive

CVS Activity Sentiment

 Insider buying over the past 3 months

CVS Activity Sentiment

 Pays a reliable dividend

 

Future

×
 

Future

3.18
 

CVS Future Sentiment

 Earnings are forecast to grow

CVS Future Sentiment

 Trading below its fair value

 
 

CVS Analysts Opinion

CVS Analysts opinion is negative and has getting worse from the past 3 months

 

CVS Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
70%
Buy
Opinion
Trend
Score
Potential
Score
 
 
0%
43%
72%
 
On Track
On Track
On Track
 

CVS Street Opinion 

CVS Street view is bullish and have positive views on the near-term outlook

 

CVS Performance Sentiment

Sentiments overview associated with the company events and the stock performance.
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
Positive vs Negative
Contrasts the positive and negative sentiments surrounding the company performance.
 
70%
26%
Positive
Negative
57 out of 82
events present
21 out of 82
events present
 
 

CVS Earnings

The Trailing Twelve Months (TTM) reflects 12-month period, providing rview of CVS financial performance.

 
Millions of Dollars
TTM
2023
2022
CAGR
 

 
Total Revenue
357,776
357,776
322,467
+5.33%
 
 
Cost of Revenue
303,345
303,345
267,965
+6.40%
 
 
Gross Profit
54,431
54,431
54,502
-0.07%
 
 
Operating Expense
39,832
39,832
38,212
+2.10%
 
 
Operating Income
14,599
14,599
16,290
-5.33%
 
 
Net Interest Income
-2,658
-2,658
-2,287
-
 
 
Interest Expense
2,658
2,658
2,287
+7.81%
 
 
Other Income
-768
-768
-8,167
-
 
 
EPS
6.53
6.49
3.29
+40.88%
 
 
Next Earnings Date: May 01, 2024
 
Highlights
Last Modify
Price
% Change

 
Strong Earnings
1 Week Ago
76.41
-0.24%
 
Strong Earnings
2 Weeks Ago
76.05
+3.09%
 
Agreements
2 Weeks Ago
72.44
-0.88%
 
Options Activity
3 Weeks Ago
73.09
-1.12%
 
HR Activity
3 Weeks Ago
73.48
+0.66%
 
 

CVS Latest News Feed
































 
 
 
joker
 
 
 
StocksRunner

Explore our CVS Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored FDX Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our CVS Daily Alerts

Access the exclusive insights that over 10,000+ subscribers value. Stay ahead in the stock market! Submit your email for daily alerts.

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Contact Us

Terms of use

Privacy Policy

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo

StocksRunner

Get the pulse of the market

 
StocksRunner
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 

CVS Rewards

 Earnings are forecast to grow

CVS Rewards

 Trading below its fair value

CVS Rewards

 Investors confidence is positive

CVS Rewards

 Insider buying over the past 3 months

 

Risk Analysis

 

CVS Risk Analysis

 Downgraded on weak valued

 
 
 

CVS Risk Level

 
 
 

The Indicator assigning risk levels based on factors such as volatility, sector strength, trading volume, investor confidence and market outlook.

 
 
CVS Risk Level
LOW
HIGH

Risk Volatility

 

CVS has Low Risk Level. Click here to check what is your level of risk

 
 
 
 

Stock Analysis

 
 
 
 

CVS

 

CVS Guidance

$ 77.20

 
+$0.10 | +0.13%
 
 
  Overview  
 
  Chart  
 
  Earnings  
 
  Sentiment  
 
  News  
 
  Updates  
 

 
joker
 
 
 
Open
$ 77.29
 
 
MKT CAP
$ 97.15B
 
High
$ 77.52
 
 
VOL
$ 4.32M
 
Low
$ 76.62
 
 
AVG VOL
$ 12.42M
 
 
 

CVS Analysis

  Sign in to view CVS Guidance (CVS) recommendation from the last 90 days from financial news and social media.
 
 

Chart

 
 

78.93

69.42

70.92

82.47

 
 
1month
3month
6month
1year
 
Total Return
CVS
vs.
S&P500
 

 
1-week Return
+0.78%
 
+1.17%
 
 
5-week Return
+4.42%
 
+6.44%
 
 
10-week Return
+4.66%
 
+10.09%
 
 
 

CVS Analysts Opinion

Overall standing by considering key factors, reflecting analysts perspectives and market expectations. Hover over the category for more information

 
 

Earnings

×
 

Earnings

3.90
 

CVS Earnings Sentiment

 Sales increase

CVS Earnings Sentiment

 Above analyst estimates

CVS Earnings Sentiment

 Revenue increase YoY

 
 

Rating

×
 

Rating

2.00
 

CVS Rating Sentiment

 Downgraded on weak valued

 

Momentum

×
 

Momentum

3.00
 

CVS Momentum Sentiment

 Price value has negative momentum

 

Activity

×
 

Activity

3.48
 

CVS Activity Sentiment

 Investors confidence is positive

CVS Activity Sentiment

 Insider buying over the past 3 months

CVS Activity Sentiment

 Pays a reliable dividend

 

Future

×
 

Future

3.18
 

CVS Future Sentiment

 Earnings are forecast to grow

CVS Future Sentiment

 Trading below its fair value

 
 

CVS Analysts Opinion

CVS Analysts opinion is negative and has getting worse from the past 3 months

 

CVS Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
70%
Buy
Opinion
Trend
Score
Potential
Score
 
 
0%
43%
72%
 
On Track
On Track
On Track
 

CVS Street Opinion 

CVS Street view is bullish and have positive views on the near-term outlook

 
CVS Performance Sentiment
Sentiments overview associated with the company events and the stock performance.
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
Positive vs Negative
Contrasts the positive and negative sentiments surrounding the company performance.
 
70%
26%
Positive
Negative
57 out of 82
events present
21 out of 82
events present
 

 

CVS Earnings

The Trailing Twelve Months (TTM) data reflects the most recent 12-month period, providing overview of CVS financial performance.

 
Millions of Dollars
TTM
2023
2022
CAGR
 

 
Total Revenue
357,776
357,776
322,467
+5.33%
 
 
Cost of Revenue
303,345
303,345
267,965
+6.40%
 
 
Gross Profit
54,431
54,431
54,502
-0.07%
 
 
Operating Expense
39,832
39,832
38,212
+2.10%
 
 
Operating Income
14,599
14,599
16,290
-5.33%
 
 
Net Interest Income
-2,658
-2,658
-2,287
-
 
 
Interest Expense
2,658
2,658
2,287
+7.81%
 
 
Other Income
-768
-768
-8,167
-
 
 
EPS
6.53
6.49
3.29
+40.88%
 
 
Next Earnings Date: May 01, 2024
 
Highlights
Last Modify
Price
% Change

 
Strong Earnings
1 Week Ago
76.41
-0.24%
 
Strong Earnings
2 Weeks Ago
76.05
+3.09%
 
Agreements
2 Weeks Ago
72.44
-0.88%
 
Options Activity
3 Weeks Ago
73.09
-1.12%
 
HR Activity
3 Weeks Ago
73.48
+0.66%
 
 
CVS Latest News Feed

CVS Factor-Based Stock Analysis. Below is Valideas guru fundamental report for CVS HEALTH CORP (CVS). Of the 22 guru strategies we follow CVS rates highest using our Acquirers Multiple Investor model based on the published strategy of Tobias Ca

Wed Feb 21, 2024

Potential

Guru Fundamental Report for CVS. Below is Valideas guru fundamental report for CVS HEALTH CORP (CVS). Of the 22 guru strategies we follow CVS rates highest using our Acquirers Multiple Investor model based on the published strategy of Tobias Ca

Sun Feb 18, 2024

Potential

Validea Detailed Fundamental Analysis - CVS. Below is Valideas guru fundamental report for CVS HEALTH CORP (CVS). Of the 22 guru strategies we follow CVS rates highest using our Acquirers Multiple Investor model based on the published strategy

Fri Feb 16, 2024

Potential

CVS Health: Lower Guidance But Risk/Reward Remains Attractive.

Thu Feb 15, 2024

Activity
Potential

CVS Health (CVS) Gains From Digital Adoption Amid Competition. CVS Health&rsquo.s CVS restructuring plan intended to streamline and simplify the organization looks impressive. However reimburse

Wed Feb 14, 2024

Activity
Activity
Potential

Heres Why You Should Retain CVS Health (CVS) Stock for Now. CVS Health Corporation CVS is well-poised for growth backed by its consistently strong sales momentum across all three operating segm

Wed Feb 14, 2024

Activity
Earnings
Momentum
Potential

CVS Quantitative Stock Analysis. Below is Valideas guru fundamental report for CVS HEALTH CORP (CVS). Of the 22 guru strategies we follow CVS rates highest using our Acquirers Multiple Investor model based on the published strategy of Tobias Ca

Tue Feb 13, 2024

Potential

CVS Health grows more cautious about 2024 as it deals with rising Medicare Advantage costs. Busy Medicare Advantage businesses have CVS Health and other insurance providers spooked about the new year CVS Health grows more cautious about 2024 as it deals w

Sun Feb 11, 2024

Activity
Activity

validea detailed fundamental analysis - cvs. below is valideas guru fundamental report for cvs health corp (cvs). of the 22 guru strategies we follow cvs rates highest using our acquirers multiple investor model based on the published strategy

Fri Feb 9, 2024

Potential

cvs health fy23 earnings: downgrades inevitable long term outlook in the balance.

Wed Feb 7, 2024

Rating

cvs health (cvs) q4 earnings top estimates 2024 eps view down. cvs health corporations cvs fourth-quarter 2023 adjusted earnings per share (eps) of $2.12 rose 3.9% year over year and exceeded t

Wed Feb 7, 2024

Earnings

cvs healths q4 earnings relieve investor concerns but lowers 2024 profit guidance citing elevated medical cost trends. on wednesday) reported fourth-quarter adjusted eps of $2.12 beating the consensus of $1.99. highlighting investors’. concerns abou

Wed Feb 7, 2024

Activity
Potential

cvs factor-based stock analysis. below is valideas guru fundamental report for cvs health corp (cvs). of the 22 guru strategies we follow cvs rates highest using our acquirers multiple investor model based on the published strategy of tobias ca

Wed Feb 7, 2024

Potential

cvs health cuts 2024 guidance due to higher medical costs. the healthcare companys revised earnings projections are likely to add to investor uncertainty about the medicare advantage business.

Wed Feb 7, 2024

Potential

cvs health grows more cautious about 2024 as it deals with rising medicare advantage costs. busy medicare advantage businesses have cvs health and other insurance providers spooked about the new year. the health care giant said wednesday that it was scali

Wed Feb 7, 2024

Activity
Activity

cvs health cuts 2024 guidance citing potential implications of higher medical costs. the healthcare companys revised earnings projections are likely to add to investor uncertainty about the medicare advantage business.

Wed Feb 7, 2024

Potential

cvs health beats top-line and bottom-line estimates. lowers fy24 outlook.

Wed Feb 7, 2024

Earnings
Potential

cvs health in charts: revenue rises q/q and y/y across all segments in q4.

Wed Feb 7, 2024

Earnings

cvs health lowers fy24 outlook - update. (rttnews) - while reporting financial results for the fourth quarter on wednesday cvs health (cvs) lowered its earnings and adjusted earnings guidance for the full-year 2024.

Wed Feb 7, 2024

Potential

cvs health corp. reports drop in q4 profit. (rttnews) - cvs health corp. (cvs) reported earnings for fourth quarter that decreased from the same period last year

Wed Feb 7, 2024

Earnings

cvs health says it is selling all 22 of its retail drugstores in puerto rico. cvs health says it has reached a deal to sell its retail drugstores in puerto rico to caribe pharmacy holdings.#cvshealth #puertorico

Mon Feb 5, 2024

Activity

cvs health unusual options activity for february 02. financial giants have made a conspicuous ish move on cvs health. our analysis of options history for cvs health (nyse:) revealed 10 unusual trades. delving into the details we found 80% of traders were

Fri Feb 2, 2024

Momentum
Potential

cvs factor-based stock analysis. below is valideas guru fundamental report for cvs health corp (cvs). of the 22 guru strategies we follow cvs rates highest using our acquirers multiple investor model based on the published strategy of tobias ca

Wed Jan 31, 2024

Potential

validea detailed fundamental analysis - cvs. below is valideas guru fundamental report for cvs health corp (cvs). of the 22 guru strategies we follow cvs rates highest using our acquirers multiple investor model based on the published strategy

Mon Jan 29, 2024

Potential

convey chooses aetna vet dan finke for ceo job. healthcare technology firm convey health solutions has named a new chief executive. dan finke who most recently served as executive vice president of cvs health and president of aetna was appointed monday (j

Mon Jan 29, 2024

Activity

notable thursday option activity: cvs ci dlr. among the underlying components of the s&.p 500 index we saw noteworthy options trading volume today in cvs health corporation (symbol: cvs) where a total of 52326 contracts have traded so far

Thu Jan 25, 2024

Momentum

cvs factor-based stock analysis. below is valideas guru fundamental report for cvs health corp (cvs). of the 22 guru strategies we follow cvs rates highest using our acquirers multiple investor model based on the published strategy of tobias ca

Wed Jan 24, 2024

Potential

validea detailed fundamental analysis - cvs. below is valideas guru fundamental report for cvs health corp (cvs). of the 22 guru strategies we follow cvs rates highest using our acquirers multiple investor model based on the published strategy

Mon Jan 22, 2024

Potential

cvs health (cvs) stock falls amid market uptick: what investors need to know. in the latest trading session cvs health (cvs) closed at $73.22 marking a -0.89% move from the previous day. the st

Fri Jan 19, 2024

Momentum

validea detailed fundamental analysis - cvs. below is valideas guru fundamental report for cvs health corp (cvs). of the 22 guru strategies we follow cvs rates highest using our acquirers multiple investor model based on the published strategy

Fri Jan 19, 2024

Potential

 
 
 
 
 

Score Tracker

 
 
 
Based on 82 events in the last 90 days from financial news and social media. Last updated Feb 23, 2024 13:28 Wall St. time
 
 

CVS Total Score

 
 
 
 
 
 
 
StocksRunner

Discover CVS Stock analysis and effective trading strategies with StocksRunner. Gain valuable insights into stock performance, market trends, and the future potential of CVS. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our CVS Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

CVS Stock trends

CVS Stock performance

CVS Stock analysis

CVS investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner ideas

Financial Reports

 
 

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
 
Post ×
 
0/666
joker